A lateral flow immunoassay test card intended for qualitative detection of SARS-CoV-2 nucleocapsid protein with FDA EUA authorization. The rapid test provides quick diagnostic results for COVID-19 detection.
Manufactured by
Xiamen Boson Biotech Co., Ltd
Xiamen, Fujian, China
Specializes in developing and manufacturing in vitro diagnostic kits, including point of care and immunoassay products for global markets. Operates a 12,500 square meter facility under ISO 13485:2016 and GMP guidelines, with products approved by China NMPA and exported to over 70 countries. Focuses on diagnostic rapid tests and offers customized solutions alongside comprehensive technical support services.
© 2026 Suplivia · Home · Browse Products